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Introduction
The San Francisco Bay Area reports some of the highest
breast cancer rates in the world [1,2]. Within this region,
appropriately adjusted breast cancer incidence and mor-
tality rates are highest in Marin County, a small, urban
county of 250,000 predominantly white, non-Hispanic res-
idents located immediately north of the city of San Fran-
cisco. Averaged over the period 1995–99, age-adjusted
invasive breast cancer rates per 100,000 white, non-His-
panic women were 199 in Marin County, 155 in the rest of
the San Francisco Bay Area, and 144 in the United States
as a whole [2]. Pronounced international and national
CI = confidence interval; NCCC = Northern California Cancer Center; NCI = National Cancer Institute; OR = odds ratio; RDD = random digit
dialing.
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Abstract
Background: This report examines generally recognized breast
cancer risk factors and years of residence in Marin County,
California, an area with high breast cancer incidence and
mortality rates.
Methods: Eligible women who were residents of Marin County
diagnosed with breast cancer in 1997–99 and women without
breast cancer obtained through random digit dialing, frequency-
matched by cases’ age at diagnosis and ethnicity, participated
in either full in-person or abbreviated telephone interviews.
Results: In multivariate analyses, 285 cases were statistically
significantly more likely than 286 controls to report being
premenopausal, never to have used birth control pills, a lower
highest lifetime body mass index, four or more mammograms in
1990–94, beginning drinking after the age of 21, on average
drinking two or more drinks per day, the highest quartile of
pack-years of cigarette smoking and having been raised in an
organized religion. Cases and controls did not significantly
differ with regard to having a first-degree relative with breast
cancer, a history of benign breast biopsy, previous radiation
treatment, age at menarche, parity, use of hormone
replacement therapy, age of first living in Marin County, or total
years lived in Marin County. Results for several factors differed
for women aged under 50 years or 50 years and over.
Conclusions: Despite similar distributions of several known
breast cancer risk factors, case-control differences in alcohol
consumption suggest that risk in this high-risk population might
be modifiable. Intensive study of this or other areas of similarly
high incidence might reveal other important risk factors
proximate to diagnosis.
Keywords: breast neoplasms, case-control study, epidemiology, risk factors
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geographic variation in breast cancer rates has been
studied extensively [3–8] and has been attributed vari-
ously to population differences in the use of mammo-
graphic screening, diet, physical activity, body size,
alcohol consumption, and socioeconomic and reproduc-
tive factors [5–7,9,10]. However, studies of breast cancer
incidence among Asian migrants to North America have
noted associations with age at migration, suggesting addi-
tional important influences of childhood or adolescent
exposures or experiences [4–6]. With regard to Marin
County, an earlier study by the Northern California Cancer
Center (NCCC) using census data suggested that the
high incidence was associated with the sociodemo-
graphic characteristics of the county and not with a geo-
graphically specific exposure [10] and that women living in
Marin County have a higher prevalence of some recog-
nized breast cancer risk factors, such as high education
and income as well as low and late parity [10,11].
In 1997, members of Marin Breast Cancer Watch, a
grassroots non-profit organization of breast cancer sur-
vivors and advocates, recruited researchers to help them
to investigate causes of breast cancer in Marin County
more thoroughly; these community members actively par-
ticipated in all aspects of conducting this study.
In this population-based case-control study of women
residing in Marin County, we asked about generally recog-
nized risk factors [5,12] and a variety of adolescent physi-
cal, psychological, and social factors. The main purpose in
this first report is to compare generally recognized breast
cancer risk factors, as well as childhood and adolescent
socioeconomic factors and years of residence in Marin
County for women with and without breast cancer.
Although it was not the purpose of this study to explain the
high rates of breast cancer in Marin County, one hypothe-
sis of the study was that if exposures specific to Marin
County were to some degree responsible for the high rates
there, one would expect women with breast cancer to have
lived longer in Marin County than control women after
adjustment for generally recognized breast cancer risk
factors. The thought was that finding such a difference
would provide justification for a more detailed exploration
of exposures specific to Marin County, whereas no differ-
ence would motivate research into other explanations.
Thus, this initial report provides important information for
planning future studies in this and other high-risk areas.
Methods
Case-control ascertainment
Eligible cases included any female resident of Marin
County with a diagnosis of primary breast cancer between
July 1997 and June 1999 if under 50 years of age, and
between July 1997 and March 1999 if 50 years old or
older at diagnosis (Table 1). Dates were chosen to yield
about 300 women overall, 100 under 50 years of age and
200 aged 50 and over. The sample size was planned with
80% statistical power to detect 2.1-fold odds ratios (ORs)
between the highest and lowest quartiles of any continu-
ous variable, 1.9-fold ORs for quartile trend, a 0.25-year
case-control difference in age at menarche, and a 3.5-year
case-control difference in years lived in Marin. Names and
addresses of these women and their physicians were
obtained from the cancer registry operated by the NCCC,
a participant in the National Cancer Institute’s (NCI’s)
Table 1
Participation rates, age and ethnicity of women with breast
cancer and controls, Marin County, California, 1997–99
Controls Cases
Variable N % N %
Eligiblesa 328 401
Study participantsb
Full interview 305 93 300 75
Short interview 16 5 36 9
Deceased 0 0 15 4
Refusal/other 7 2 50 12
Total 328 401
Ethnicity
White 98 94
Full interview 300 285
Short interview 16 30
Non-white 2 6
Full interview 5 15
Short interview 0 6
Total 321 336
Age Mean ± SEM Median Mean ± SEM Median
Full interview 55.1 ± 0.36 55 55.4 ± 0.55 55
Short interview 55.8 ± 2.83 55 56.7 ± 1.93 58
All women 55.2 ± 0.54 55 55.6 ± 0.53 55
aCases eligibility: less than 50 years old, newly diagnosed with primary
breast cancer between 1 July 1997 and 30 June 1999 or at least
50 years old and diagnosed between 1 July 1997 and 22 March 1999.
For controls, 3945 random digit numbers were called: 1640 (41%)
either were not in service, were a business, fax or modem number, or
were outside Marin County; 920 (23%) were reached but no resident
was eligible; 289 (7%) yielded refusal with no additional information;
733 (19%) were in service but were either busy or did not answer (of
which 394 were closed out after 10 call attempts and 339 had fewer
than 10 call attempts made and were not closed out by the time that
control recruitment ended); and 347 (9%) yielded an eligible subject.
Of 347 women identified as eligible, 328 were contacted.
bFive control women refused any participation and two could not be
contacted. Thirty-six cases refused any participation, physicians
refused contact for three cases, two cases could not be interviewed in
English, we were unable to contact six cases, and three cases were
mistakenly coded as ineligible.
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Surveillance, Epidemiology, and End Results program.
After receiving an introductory letter, women who did not
refuse by postcard were telephoned by a study interviewer
to arrange a time and place for the in-person interview.
Control women without breast cancer were ascertained
through random digit dialing (RDD) by using a modifica-
tion of the method of Waksberg [13,14] and were fre-
quency-matched to cases by age at diagnosis (within
5 years) and ethnicity. To maximize the chances of reach-
ing residential numbers, seed numbers used for dialing
included the area code plus the first five digits of the
study’s cases and all cancer cases diagnosed in Marin
County in 1998. All possible numbers other than the
cases’ numbers were generated and randomly sorted. The
RDD contractor also generated a batch of about 300
random numbers from marketing sources to increase the
number of calls to households with women aged 65 years
and older. Randomly sorted numbers were called sequen-
tially. Two survey research companies (Survey Methods,
and Field Research Corporation, both of San Francisco,
California) conducted RDD and preliminary eligibility
screening of controls. RDD was conducted from April
2000 to August 2001.
The University of California, San Francisco, Committee on
Human Research approved the study methods, and
informed consent was obtained from all participants.
Interviews
The approximately 2-hour in-person interviews were con-
ducted at a place of each subject’s choosing. Because
many questions required the recall of adolescent factors,
the interview used three memory tools developed during
the pilot phase of this study: a visualization exercise, a
magnetic memory board, and photographs of girls at
various stages of development in a variety of social set-
tings. The magnetic memory board consisted of a sheet
with rows showing the subject’s age (0–20 years), the
corresponding year, and memorable historic events that
occurred during each year. As women went through the
questionnaire, magnets with major life events (such as
moves, school changes, births and deaths in the family)
were placed in the appropriate row for the age or year in
which the events occurred. All contemporary factors were
asked of cases up to or around diagnosis date and of con-
trols, up to the date of interview. The questionnaire
included factors that have been summarized elsewhere
[5,12] as being either established or strongly suspected
risk factors for breast cancer. Women who did not wish to
participate in the full interview were asked to complete a
brief telephone interview that included a subset of the full
interview questions.
Questionnaire items pertinent to this report included
detailed residential and school histories before age
21 years (such as location, ownership or rental, and dates
in and out), highest level of schooling; total time of resi-
dence in Marin and other parts of the San Francisco Bay
Area throughout the lifetime; ethnicity; childhood religion;
parents’ highest level of education and occupational char-
acteristics at subject’s age 5, 12, and 18 years; other
measures of family’s socioeconomic conditions including
self-assessed socioeconomic status currently and before
age 21 years; ages at menarche and menopause, and
menopausal status; alcohol use and tobacco use and
exposures; reproductive and breastfeeding history; family
history of breast cancer; type and ages of use of female
hormones; previous non-breast cancers; breast and cervi-
cal cancer screening practices; breast procedures; radia-
tion treatments before breast cancer; and body weight
and height at various times in life not including the times
that the woman was pregnant or nursing or during the first
6 months after pregnancy.
Case interviews were conducted from December 1999 to
September 2001 and control interviews were conducted
from April 2000 to September 2001.
Data analysis methods
We computed frequencies of categorical variables and
means, standard errors, and medians of continuous vari-
ables separately for cases and controls. Continuous data
also were categorized into quartiles determined by the
control group distributions. Analysis of variance was used
to compare unadjusted means and Wilcoxon tests were
used to compare medians of continuous variables for
cases and controls. Case-control ORs and 95% CIs were
estimated for categorical and quartiled data by using
logistic regression. Preliminary analyses made adjust-
ments for 5-year age groups; these analyses included tele-
phone interview respondents for variables asked in both
the full and abbreviated interviews. After a review of
results of the preliminary age-adjusted analyses, a subset
of the many variables was selected for inclusion in a multi-
variate model; these included variables that are estab-
lished or strongly suspected risk factors for breast cancer
that might confound other results and those that were sta-
tistically significant in age-adjusted comparisons. Age was
included in all models. In addition, ORs for residential
history variables were adjusted for other variables
included in the multivariate model, but not for each other,
because the various residential variables were not mutu-
ally exclusive. Multivariate ORs were estimated with logis-
tic regression and included only those subjects with
in-person interviews and non-missing data for all the vari-
ables in the model.
Analyses were conducted across all age groups as well as
separately for women under 50 years of age and 50 years
of age and older. These two age groups were chosen for
separate analyses before any data collection, because the
direction and magnitude of several important breast
cancer risk factors seem to vary by age [12]. Furthermore,
we specifically chose not to analyze women separately by
premenopausal and postmenopausal status, because the
many perimenopausal women do not readily fit into either
category. ORs of less than 1 are given two decimal
places; those greater than or equal to 1 are given one
decimal place to achieve comparable accuracy.
Residences at birth and before age 21 years were grouped
into eight broad geographic regions based on the geo-
graphic variation of breast cancer mortality as shown in the
NCI’s Atlas of Cancer Mortality [15]. These regions were
Northeast (Maine, New Hampshire, Vermont, Massachu-
setts, Connecticut, New Jersey, New York, Pennsylvania,
Delaware, Washington, DC, Rhode Island, and Maryland);
Great Lakes (Minnesota, Iowa, Illinois, Wisconsin, Michi-
gan, Indiana, and Ohio); Plains (North Dakota, South
Dakota, Nebraska, Kansas, and Montana); South (Okla-
homa, Missouri, Arkansas, Louisiana, Mississippi, Alabama,
Tennessee, Kentucky, West Virginia, Virginia, North Car-
olina, South Carolina, Georgia, Florida, and Texas); West
(Idaho, Wyoming, Utah, Colorado, Arizona, New Mexico,
Alaska, and Hawaii); Northwest (Washington, Oregon, and
Nevada); California; and not in the USA.
Results
Subject ascertainment and interviews
Table 1 shows participation rates for cases and controls,
and the footnote gives details on the numbers and disposi-
tion of calls made through RDD. Ages and ethnicities of
cases and controls that completed the full interview were
very similar by study design (Table 1). Because only 15 eli-
gible women (about 4%) had died by the time of the study,
we did not conduct proxy interviews. Of the 305 cases and
300 controls completing the in-person interview, complete
data for all variables considered in the multivariate model
were available for 285 cases and 286 controls.
Risk factors
Personal and family health history
As shown in Table 2, there were no substantial or statisti-
cally significant differences in the frequencies of cases
and controls reporting a first-degree relative with breast
cancer or a history of benign breast biopsy. Cases were
somewhat more likely than controls to report previous radi-
ation treatments for conditions other than breast cancer
and the OR was significantly elevated in women under the
age of 50 years (Table 2). However, on closer inspection
four cases and four of the controls reported radiation
treatments to the upper body, whereas two cases and no
controls reported radiation treatment for plantar warts.
There were no differences in average or median age at
menarche for cases and controls (average was 12.6 ± 0.1
for cases and 12.5 ± 0.1 for controls) and no statistically
significant trends with age at menarche in either age
group (Table 2). Among women under the age of
50 years, cases were about half as likely as controls to
have begun menarche at age 15 years or older, but the
results were not significant (Table 2). In both age groups,
cases were more likely to be premenopausal at diagnosis
than controls at a similar age (Table 2). Similar proportions
of cases (6.7%) and controls (7.3%) reported having had
both ovaries removed; 2% of cases and 1% of controls
had both ovaries removed before age 40 years. Cases
were more likely than controls to have had a history of
uterine or ovarian cancer (OR = 3.0; 95% CI, 0.60–15.1),
but the result was not statistically significant.
Some of the associations of reproductive factors differed
by age group. Among women aged 50 years and older,
compared with women who had never been pregnant,
cases were more than twice as likely as controls to have
been pregnant or parous, without breastfeeding (Table 2).
However, there were no differences between these cases
and controls in average age at first pregnancy
(25.1 ± 0.4 years for cases and 24.7 ± 0.4 years for con-
trols) or at first birth (26.0 ± 0.4 years for cases and
25.9 ± 0.4 years for controls) and no suggestions of
trends with numbers of births (Table 2). Among women
who breastfed, there was no difference between cases
and controls in duration of breastfeeding (mean durations:
12.2 ± 1.2 months for cases, 12.8 ± 1.3 months for con-
trols; categorized data presented in Table 2). Among
women under the age of 50 years, cases were more likely
than controls to have never been pregnant, but the differ-
ences were not statistically significant (Table 2). In catego-
rized data, women with three or more births, or more than
12 months of breastfeeding, had significantly reduced
ORs compared with women who were never pregnant
(Table 2). As with women aged 50 and older, there were
no trends evident for and no differences in average ages
at first pregnancy (cases 25.4 ± 0.8 years; controls
26.3 ± 0.7 years) or first birth (cases 30.1 ± 0.9 years;
controls 30.4 ± 0.7 years).
Significantly fewer cases than controls had ever used
birth control pills in both age groups (Table 2). There
were no apparent trends with total time used; compared
with women who never used birth control pills, the use of
birth control pills for up to 2 years, 2–6 years,
6–10 years, and more than 10 years had ORs of 0.55
(95% CI, 0.33–0.93), 0.52 (95% CI, 0.30–0.89), 0.57
(95% CI, 0.32–1.0), and 0.47 (95% CI, 0.27–0.82),
respectively. There was also no difference with current
use versus past use.
About equal percentages of cases (54.7%) and controls
(55.9%) had ever taken hormone replacement therapy and
there were similar percentages who had taken combina-
tion therapy (Table 2).
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Cases and controls had similar average and median
maximum lifetime heights of about 65 inches (165 cm).
There were no notable differences in highest or lowest
postpubertal body mass index before age 21 years (the
median highest body mass index for both cases and con-
trols was 20.6 kg/m2, and the median lowest body mass
index was 18.5 kg/m2 for cases and 18.6 kg/m2 for con-
trols) or in lowest body mass index after age 21 years.
However, in both age groups, the highest body mass
index after age 21 years was lower in cases than in con-
trols (the median highest body mass index was 23.9 kg/m2
for cases and 25.0 kg/m2 for controls); categorized data
are presented in Table 2. A similar result was found by
using body mass index 1 year before diagnosis for cases
and before interview for controls.
We also conducted an analysis of perimenopausal and
postmenopausal women that stratified body mass index by
hormone replacement therapy use, adjusting for other vari-
ables in the multivariate model: in comparison with women
who had not used hormone replacement therapy and had
a body mass index of less than 25 kg/m2, cases were sig-
nificantly less likely than controls to report a highest body
mass index of more than 30, regardless of whether they
had used hormone replacement therapy (OR = 0.36; 95%
CI, 0.14–0.89) or not (OR = 0.24; 95% CI, 0.08–0.75).
Over all and in both age groups, cases were more than
twice as likely as controls to have had four or more mam-
mograms during the period 1990–94 (Table 2). Regarding
other factors related to health care access and use, all but
2% of cases and 1% of controls had health insurance. For
the period 1990–94, among women under the age of
50 years, cases were somewhat less likely than controls
(83% versus 92%) to have clinical breast exams yearly or
more often, whereas cases and controls were about
equally likely (89% of cases and 94% of controls) to have
an annual or more frequent pelvic exam. During this same
period, for women aged 50 years and older, about 92% of
cases and 83% of controls reported annual or more fre-
quent clinical breast exams, and 93% of cases and 87%
of controls reported annual or more frequent pelvic exams
and pap tests.
Socioeconomic factors
Over all ages, there were no meaningful or statistically sig-
nificant differences between cases and controls for
current or past socioeconomic indicators, except that
cases were more likely than controls to report their family’s
socioeconomic strata before age 21 years as ‘upper’
(Table 2). However, no difference was noted when women
in this small category of women (3.9% of cases and 0.7%
of controls) were combined with the ‘upper middle’ cate-
gory (Table 2). The self-reported socioeconomic status at
the time of diagnosis for cases and interview for controls
was very similar for cases and controls: 9% of cases and
11% of controls reported their status as ‘poor’, ‘working
class’ or ‘lower middle’, 36% of both cases and controls
reported ‘middle’ and 55% of cases and 53% of controls
reported ‘upper middle’ or ‘upper’. Both cases and con-
trols had a median of 16 years of education.
There was some indication that case-control associations
of socioeconomic factors differed between women 50 years
and older and those under 50 years. For example, among
women aged 50 years and older, cases were more likely
than controls to report their family socioeconomic status
as ‘upper or upper middle’ before age 21 years (Table 2).
Although this finding was largely due to the small group of
women classifying themselves as ‘upper’, consistent with
this was the observation that 33% of cases versus 22% of
controls reported their fathers to have been self-employed
or business owners when the subjects were 5 years old
(P < 0.05). In contrast, among women under 50 years old
there was a non-significant inverse association with
increasing self-reported family socioeconomic status
before age 21 years (Table 2). Consistent with this was
the observation that case families spent significantly more
time on average than control families in rental residences
before age 21 years (6.2±0.7 years versus 4.4±0.5 years;
P = 0.03) and cases were less likely than controls to
report that their fathers had a college degree (40% versus
54%; P = 0.05) or that their father held a supervisory posi-
tion (for example, 50% versus 65% at subject’s age 5;
P = 0.05).
Religion
Over all ages, significantly fewer cases than controls were
raised with no specific religion, and among women aged
50 and over cases were less likely than controls to report
having been raised in religions other than Protestant,
Catholic, or Jewish (Table 2).
Alcohol consumption
Women with breast cancer were significantly less likely
than control women to report having drunk alcoholic bever-
ages before age 21 years (Table 2). Consistent with this
finding was the fact that cases also reported significantly
fewer average or median numbers of drinks than controls
before age 21 years (median 90 versus 120; P=0.01).
However, women with breast cancer reported a higher fre-
quency of drinking alcohol after age 21 years than controls,
and there was a trend with increasing average frequency of
drinking irrespective of age group (Table 2) that was statis-
tically significant among women less than 50 years old.
Tobacco exposures
Although equivalent percentages of cases and controls
had ever smoked cigarettes (59% and 55%, respectively),
cases were more likely than controls to report more than
28.5 pack-years (Table 2; 28.5 years was the cutoff point
for the upper quartile of pack-years smoked among con-
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trols). This association was also significant for women
aged 50 and over, but there was no trend with increasing
pack-years smoked below the highest quartile (Table 2).
With regard to passive exposure to tobacco smoke, 81%
of cases and 79% of controls had ever lived in a house-
hold with a smoker before age 21 years, and 60% of
cases and 62% of controls had ever lived in a household
with a smoker after age 21 years, with no trend for dura-
tion of exposure in either age group.
Residence history
As shown in Table 3, there were no substantial differences
in geographic area of birth or places ever lived before age
21 years among women overall or women over age
50 years. However, among women under the age of
50 years, a significantly higher percentage of cases than
controls reported having been born in or having ever lived
in the Northeast or Great Lakes areas before age 21 years
(only geographic areas with noteworthy differences are
included in the table).
Over all ages and among women aged 50 years and over,
there were no notable case-control differences in the age
of first living in Marin County, years before the age of 21 or
lifetime years lived in Marin County or lifetime years lived in
the San Francisco Bay Area (Table 3). Among women
under the age of 50 years, cases had lived significantly
fewer years than controls in other parts of the San Fran-
cisco Bay Area, but had similar durations of living in Marin
County (Table 3).
Discussion
In this article we have focused on comparisons of generally
accepted or suspected risk factors for breast cancer,
including some characteristics measured both for adult-
hood and adolescence. Interestingly, cases and controls
were strikingly similar for several factors known to influence
breast cancer risk (such as family history of breast cancer,
contemporary socioeconomic status, age at first birth, or
use of hormone replacement therapy). For instance,
although the overall rate of positive first-degree family
history (19%) among cases is similar to that reported in
other recent series [16,17], the controls in this population
had rates of family history comparable to those of the
cases. One possible explanation for the homogeneity of
cases with regard to these factors could be our focus on
residents of a small, relatively homogenous, and affluent
area, Marin County. The homogeneity of the Marin County
population is supported by recent maps showing little vari-
ation in standardized incidence rate ratios for breast cancer
among the census tracts within Marin County [18].
Another explanation could involve preferential participation
in the study by controls with these recognized breast
cancer risk factors over those without these factors. This
seems unlikely given the high participation rates among
those found to be eligible on the basis of RDD, but it is
possible that there was some selection bias in women or
households who were willing to answer the telephone call
screening for eligibility. Further studies with alternative
control ascertainment methods would be necessary to
resolve this issue. In addition, appropriately adjusted com-
parisons of these factors in this high-risk area versus geo-
graphic areas with lower breast cancer rates would be
needed to answer the question of how much of the excess
of breast cancer incidence in Marin County might be due
to patterns of these risk factors. Such a study is currently
underway. A study that uses risk factor prevalence data
from this study and other sources is also underway to esti-
mate the attributable proportions of breast cancer due to
specific risk factors.
As mentioned above, selection bias due to differential par-
ticipation by cases or controls with some risk factor of
interest is always a potential concern in case-control
studies. In attempts to minimize this problem, we sought an
abbreviated interview for those cases and controls not able
or willing to participate in the full interview. The preliminary
age-adjusted analyses of individual risk factors used all
women for whom information was available. There were not
any notable differences in magnitude of the age-adjusted
ORs that used all 657 participants and the multivariate
results based on 571 subjects with complete information.
Despite homogeneity in current socioeconomic status, our
study suggests that among women aged 50 years and
older, breast cancer cases might have been more likely
than controls to have grown up in more affluent families,
although the results are largely due to the small proportion
of subjects reporting their family’s socioeconomic status
as ‘upper’ before age 21 years. In contrast, for women
under the age of 50 years, breast cancer cases were
somewhat less likely than controls to have grown up in
more affluent families. That an effect of pre-adult socio-
economic status existed in the women aged 50 and over
that was independent of contemporary socioeconomic
status as well as established reproductive, menstrual, and
other factors such as body size and alcohol consumption
suggests that further attention is needed to understand
the relationship of childhood or adolescent socioeconomic
factors and breast cancer.
Almost all women in this study had health insurance, and
whereas women with breast cancer were more likely than
controls to report having had four or more mammograms
in the period 1990–94, they were about equally likely to
report obtaining pelvic exams over the same period. This
suggests that women who subsequently developed breast
cancer might have had more mammograms than controls
because they had more breast problems rather than
because they were, in general, more regular users of
cancer screening services than controls.
Available online http://breast-cancer-research.com/content/5/4/R88
R97
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Interestingly, in both age groups, women who had given
birth but had not breastfed had a higher risk for breast
cancer than women who had never been pregnant,
women who had been pregnant but not parous, and
women who had been parous and breastfed, although the
result was statistically significant only in those aged
50 years and older. In addition, among women under the
age of 50 years, women who breastfed for 12 months or
more had significantly reduced odds of breast cancer.
This finding is consistent with a large collaborative study
[19] showing breastfeeding to be protective for breast
cancer through hormonal or other mechanisms. That
report suggested an urgent need to fully understand the
mechanisms of the protective effect of breastfeeding so
that some intervention mimicking breastfeeding could be
developed and offered to women who have not breastfed.
It is also possible that inability to lactate or suppressing
lactation after giving birth might have a deleterious effect
on breast physiology [20], but we did not request this
information from subjects. Given the relatively late ages of
first birth in this population, one might not expect to see a
protective effect of having ever given birth, because the
well-established protective effects of pregnancy seem to
be reversed for first births at about age 30 years or later
[21,22]. This study had a higher percentage of nulli-
parous women (25% of cases and 26% of controls) than
a recent study conducted in the Seattle area (13% of
cases and 14% of controls) [17]. However, the California
Teachers Study cohort, with a similarly elevated rate of
invasive breast cancer of 151 per 100,000 person years
among non-Hispanic white women between 1995 and
1998, reported a similar percentage of nulliparous
women (27%) among participants without breast cancer
in 1995 [23].
Consistent with previous findings [12] was our observa-
tion that cases were more likely to be premenopausal than
controls, suggesting a later age at menopause. Despite
the absence of a strong difference in age at menarche
between cases and controls in this group, those women
who developed breast cancer had relatively later
menopause, indicating a greater number of years of active
menstruation. Starting menarche at age 11 years or earlier
is considered an established breast cancer risk factor, and
starting menarche at age 15 years or older is considered
an established protective factor [12]. In the present study,
cases were somewhat less likely than controls to start
menarche at age 15 years or older, but cases were not
more likely than controls to have early menarche. A similar
lack of association of age at menarche with breast cancer
status was apparent in the large recent study by March-
banks and colleagues [16]. The distribution of age at
menarche reported by control women in Marin County
was similar to that observed for women in the California
Teachers Study cohort [23].
Disagreement remains in the literature on the direction and
magnitude of effect, if any, of oral contraceptives on
breast cancer risk [12,16,24]. Despite large studies
designed to address such differences, chance, selection
factors, changes in formulations, patterns of use, and dif-
ferent background risk for breast cancer might account for
some of the variation in findings. In this Marin County
study, we found a rather strong and significant inverse
association of oral contraceptive use and breast cancer.
However, the lack of case-control differences by duration
or latency of use argues against a causal connection and
suggests that oral contraceptive use might be a surrogate
for some other protective behavior or exposure. Given the
very high rate of use of oral contraceptives in this popula-
tion, an alternative explanation could be that factors or
conditions contraindicating the use of oral contraceptives
might increase the risk for breast cancer. In future studies
it might be worthwhile to assess why women chose to
use, or not to use, oral contraceptives.
In addition, there was no indication of large differences in
hormone replacement therapy use among cases and con-
trols, which was similar to a recent Seattle case-control
study [17], although any use of hormone replacement
therapy was somewhat higher in the Marin population
(55–56%) than in the women in the Seattle study
(49–51%). In addition, the specificity of questions about
types of hormone replacement therapy used and the sample
size of this Marin study is insufficient to rule out the small
increased risk (25–30%) observed in larger studies [25,26]
or to examine in detail different hormone replacement
therapy regimens, duration, or age of use. Appropriately
adjusted comparisons of rates of hormone replacement
therapy use in this area and geographic areas with lower
breast cancer rates would be informative regarding the rela-
tionship of hormone replacement therapy use to the ele-
vated breast cancer incidence in Marin County.
Many studies have examined breast cancer in relation to
body weight, height, and overall body size (as measured
by body mass index). The general consensus has been
that increased height might be associated with increased
risk for breast cancer, and that obesity might increase risk
in women aged 50 years or over or who are post-
menopausal but might decrease risk in women under the
age of 50 years [27–30]. Highest adult body mass index
was strongly inversely related to breast cancer status
both in women under the age of 50 years and, unexpect-
edly, in those aged 50 years and older. The average
highest body mass indexes reported in this study (24.9
and 26.5 kg/m2 for cases and controls, respectively) were
in the same range reported for subjects’ body mass index
5 years previously in a recent large US study (25.5 and
25.8 kg/m2 for cases and controls, respectively) [16] and
participants in the California Teachers Study in 1995
(24.8 kg/m2) [23].
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One explanation for the finding could be that mechanisms
of weight maintenance might have contributed to the asso-
ciation. Because we did not ask about adult or recent physi-
cal activity in the interview, we cannot assess the impact of
these factors on the body size results. In the Nurses’ Health
Study cohort, Huang and colleagues [31] reported that
among postmenopausal women, weight gain was consis-
tently associated with an increased risk for breast cancer
only among women who had not used hormone replace-
ment therapy. We found that cases had lower highest body
mass index than controls both among women who had
used hormone replacement therapy and among women
who had not. It is possible in this affluent community that
perimenopausal and postmenopausal women who are not
taking prescribed hormone replacement therapy could be
eating foods or taking herbal or other non-prescribed sup-
plements to ameliorate menopausal symptoms that might
simulate the effects of hormone replacement therapy. Unfor-
tunately we did not collect the data to test this possibility,
but such questions should be included in future studies.
Alcohol use has been increasingly associated with both
premenopausal and postmenopausal breast cancer risk
[32,33], including a report from the California Teachers
Study, showing that recent alcohol consumption increases
risk for breast cancer [34]. We found that although
women with breast cancer were less likely than controls to
have begun drinking alcohol before age 21 years, they
were much more likely than controls to consume two or
more drinks per day on average as adults. That the ORs
for alcohol consumption in this study were generally
higher than those reported in other studies suggests a
possible interaction of alcohol consumption with other
factors that have a high prevalence in this population.
Cigarette smoking has not been consistently associated
with breast cancer risk [12]. The elevated OR observed in
this study for the highest quartile of pack-years smoked
might be due to differential participation by controls with a
lower pack-year history or differential reporting of smoking
history by cases and controls. It is also possible that
smoking history was confounded by factors not measured
in this study, such as physical activity.
For women under the age of 50 years, women with breast
cancer were much more likely than controls to have been
born or lived before age 21 years in the Northeastern or
Great Lakes regions of the USA, regions that were in the
upper deciles of breast cancer mortality both for the period
1950–69 and for the period 1970–94 [15]. Geocoding
and other refinements of residence information might help
to clarify which areas of first or early life residences might
be associated with later risk for breast cancer.
The similar average ages of first residence and total years
lived in Marin for cases and controls do not support (but
cannot completely rule out) the hypothesis that there is
some agent specific to Marin County, such as a particular
water source, that might increase the risk for breast
cancer. These findings do not imply that environmental
factors are unimportant in breast cancer causation. On the
contrary, our and others’ findings of increased risk with
frequency of alcohol consumption show that a woman’s
personal environment can strongly influence her breast
cancer risk. In addition, our result of higher risk among
women under the age of 50 years who lived in the North-
east or Great Lakes regions before age 21 years might
suggest a role of early environmental factors.
Because control women in this study had such high rates
of health insurance and use of basic screening services, it
seems likely that they truly did not have breast cancer at
the time of interview. This was despite a higher proportion
of controls with established breast cancer risk factors
such as family history and nulliparity than observed in
control subject groups in other recent studies. Given this
observation, a further intensive study of this or other simi-
larly high-incidence populations might reveal factors proxi-
mate to breast cancer diagnosis that could enrich our
understanding of breast cancer etiology in a high-inci-
dence population. Some provocative clues from this first
analysis suggest that some as yet unidentified correlate of
oral contraceptive use might be protective and that con-
suming two or more alcoholic drinks per day might be
deleterious for women in this high-incidence population.
We were unable to examine the effects of other provoca-
tive exposures previously proposed by others, including
exposures to light at night [35] and polycyclic aromatic
hydrocarbons [36]. The observed early socioeconomic dif-
ferences combined with a lack of differences in age at
menarche or early body size also suggest that attention
might be turned to patterns of early infection (or lack of
infection) and immune response [37].
This study is among the first reported in which community
advocates took part in all aspects of the research process,
from formulating questions of interest and questionnaire
design to monitoring progress of subject recruitment and
data analysis and interpretation at regular meetings. This
study provides important information for planning addi-
tional studies to understand reasons for breast cancer in
this or other high-risk geographic areas characterized by a
socioeconomically affluent population.
Conclusions
Women with breast cancer and controls had very similar
distributions of age of first living and years lived in Marin
County, suggesting that the County’s high breast cancer
rates are probably not due to geographically specific
exposures. Despite similar distributions for several known
breast cancer risk factors, case-control differences in
alcohol consumption suggest that breast cancer risk in
Available online http://breast-cancer-research.com/content/5/4/R88
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this population might be modifiable. This study might be
useful to communities and researchers concerned with
understanding the basis of, and means of mitigating, high
local or regional rates of breast cancer. Intensive study of
high-incidence areas might reveal other important risk
factors proximate to diagnosis.
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